Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration.
The factors controlling the transfection efficiency of cationic lipid carrier systems following intravenous administration are poorly understood. Using N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethylammonium chloride (DOTMA) combined with Tween 80 as a carrier system and cDNA of luciferase or beta-galactosidase gene as a reporter, we investigated the importance of DOTMA to DNA ratio and the ratio of DOTMA to Tween 80 in the lipid formulation in determining the site and level of transgene expression following intravenous administration. The data show that all of the internal organs, including lung, liver, spleen, heart and kidneys, expressed the transgene upon systemic administration into animals with 25 micrograms of plasmid DNA when complexed with DOTMA-Tween 80 lipid formulation. The transfection efficiency was dependent on both DOTMA to DNA, and DOTMA to Tween 80 ratios. Among the organs examined, the lung appeared to be more transfectable than other organs. A better transfection activity was obtained with higher DOTMA to DNA and DOTMA to Tween 80 ratios. Time-response curve shows that gene expression was transient with a maximal level between 10 and 24 h after injection. Results from tissue distribution studies with 125I-labeled plasmid DNA and Southern analysis suggest that the transient expression is the result of the loss of transgene from the transfected cells. These results suggest that cationic lipid-based delivery systems can be efficient for gene delivery if the composition of the DNA-lipid complexes is properly controlled.
Liu
F
F
Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, PA 15201, USA.
Qi
H
H
Huang
L
L
Liu
D
D
D000818:Animals; D015139:Blotting, Southern; D002412:Cations; D018076:DNA, Complementary; D015870:Gene Expression; D015316:Genetic Therapy / Q000379:methods*; D006651:Histocytochemistry; D007275:Injections, Intravenous; D008081:Liposomes; D008156:Luciferases / Q000235:genetics; D008168:Lung / Q000378:metabolism*; D051379:Mice; D008815:Mice, Inbred Strains; D010957:Plasmids; D011136:Polysorbates / Q000008:administration & dosage*; D000644:Quaternary Ammonium Compounds / Q000008:administration & dosage*; D013997:Time Factors; D014018:Tissue Distribution; D014162:Transfection / Q000379:methods*; D019076:Transgenes; D001616:beta-Galactosidase / Q000235:genetics
D002412:Cations; D018076:DNA, Complementary; D008081:Liposomes; D011136:Polysorbates; D000644:Quaternary Ammonium Compounds; C054005:N-(1-(2,3-dioleyloxy)propyl)-N,N,N-trimethylammonium; D008156:Luciferases; D001616:beta-Galactosidase